News/Events

Professor Gordon Dougan - Antimicrobial Resistance theme lead
Gold medal for Professor Gordon Dougan

Professor Gordon Dougan has been awarded the Albert B. Sabin Gold Medal. The award is given to a distinguished member of the global health community who has made extraordinary contributions to vaccinology or a complementary field.Read more

Cytosponge
Sponge on a string test to transform oesophageal cancer diagnosis

A ‘sponge on a string’ pill test can identify ten times more people with Barrett’s oesophagus than the usual GP route, according new research. Read more

alt=""
New NHS service enables people to sign up to be contacted for COVID-19 vaccine studies

A new NHS service has been launched, helping people across the UK sign up for information on the new COVID-19 vaccine trials.Read more

alt=""
Transgender and gender-diverse individuals are more likely to be autistic and report higher autistic traits

Transgender and gender-diverse adults are three to six times more likely as cisgender adults to be diagnosed as autistic, according to a new Cambridge study.Read more

alt=""
New funding boost to speed up diagnosis in oesophageal cancer

Cambridge will lead on improving early detection in oesophageal cancer as part of a Government backed projectRead more

alt=""
National research platform launches new website

The address is the same, but the next time you visit the NIHR BioResource website, you’ll see it has a brand new look, ready for researchers and the public.Read more

alt=""
TACTIC-E trial to test whether a simple microbe could be an effective treatment for COVID-19

As part of a new trial, a microbe will be used to treat severe COVID-19 in an experimental drug known as EDP1815. Read more

alt=""
Phased re-start of non-COVID-19 research

In line with NIHR guidance, we are beginning the process of phased re-opening of some non-COVID-19 research studies, while maintaining our contribution to local and nationally prioritised urgent public health studies for COVID-19.Read more

alt=""
Rapid COVID-19 test halves patient waiting times

A new diagnostic test that can diagnose COVID-19 in a hospital setting faster than standard testing methods has been able to halve patients waiting times.Read more

alt=""
Cambridgeshire Trusts join COVID-19 vaccine trial

Three leading NHS Trusts in Cambridgeshire are collaborating on a COVID-19 vaccine trial which has been developed by the University of Oxford.Read more

alt=""
Prestigious fellowship election for NIHR Cambridge BRC researchers

The NIHR Cambridge BRC is delighted that three of our researchers have been elected as Fellows of the Academy of Medical Sciences.Read more

Prolific study logo
Cambridge study to trial widely used drug to protect healthcare staff from COVID-19.

The PROLIFIC study (ChemoPROphyLaxIs For covId-19 infeCtious disease) aims to determine whether hydroxychloroquine (HCQ), a widely used anti-malarial drug, is effective at preventing or reducing COVID-19 infection in frontline healthcare workers.Read more

Discover more about the NIHR Cambridge BRC

Contact us by phone, email or web for more information.

Events Calendar

Listing relevant events and training sessions for researchers and members of the public.